NEW YORK (GenomeWeb News) – Cancer Genetics today said that it was awarded $1.8 million from New Jersey's Technology Business Tax Certificate Transfer program.

The program allows technology and biotechnology businesses with net operating losses to sell their unused net operating loss carryover and unused R&D tax credits for at least 80 percent of the value of the tax benefits to a profitable corporate taxpayer in New Jersey that is not an affiliated business. The $1.8 million awarded to Cancer Genetics is net of transaction costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.